Eunju Nam

Eunju Nam

Auto-generated profile, based on publicly available information

Eunju Nam

Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2022 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
JHJiyeon Han
Jiyeon Han
JYJiwon Yoon
Jiwon Yoon
JSJeongcheol Shin
Jeongcheol Shin
ENEunju Nam
Eunju Nam
TQTongrui Qian
Tongrui Qian
MLMi Hee Lim
Mi Hee Lim

4 July 2024 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
KLKwangwoon Lee
Kwangwoon Lee
MBMarco Barone
Marco Barone
AWAmanda L. Waterbury
Amanda L. Waterbury
HJHanjie Jiang
Hanjie Jiang
ENEunju Nam
Eunju Nam
PCPhilip Cole
Philip Cole

28 August 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MAMaheeshi Yapa Abeywardana
Maheeshi Yapa Abeywardana
SWSamuel D. Whedon
Samuel D. Whedon
KLKwangwoon Lee
Kwangwoon Lee
ENEunju Nam
Eunju Nam
RDRafael Dovarganes
Rafael Dovarganes
PCPhilip Cole
Philip Cole
Sirtuin 2 (Sirt2) is a member of the sirtuin family of NAD-dependent lysine deacylases and plays important roles in regulation of the cell cycle and gene expression. As a nucleocytoplasmic deacetylase, Sirt2 has been shown to target both histone and nonhistone acetylated protein substrates. The central catalytic domain of Sirt2 is flanked by flexible N and C termini, which vary in length and composition with alternative splicing. These termini are further subject to posttranslational modifications including phosphorylation. Here, we investigate the function of the N and C termini on deacetylation of nuclear substrates by Sirt2. Remarkably, we find that the C terminus autoinhibits deacetylation, while the N terminus enhances deacetylation of proteins and peptides, but not nucleosomes-a chromatin model substrate. Using protein semisynthesis, we characterize the effect of cell cycle-linked N-terminal phosphorylation at two major phosphorylation sites (Ser23/Ser25) and find that these further enhance protein/peptide deacetylation, with no effect on nucleosome deacetylation. Additionally, we find that VRK1, an established binding partner of both Sirt2 and nucleosomes, can stimulate deacetylation of nucleosomes by Sirt2, likely through an electrostatic mechanism. Taken together, these findings reveal multiple mechanisms regulating the activity of Sirt2, which allow for a broad range of activities across its multiple biological roles.

26 March 2025 in Journal of Biological Chemistry
Verified
Journal Article
Open access
ZWZhipeng A. Wang
Zhipeng A. Wang
JMJonathan Markert
Jonathan Markert
SWSamuel D. Whedon
Samuel D. Whedon
MAMaheeshi Yapa Abeywardana
Maheeshi Yapa Abeywardana
XSXinlei Sheng
Xinlei Sheng
PCPhilip Cole
Philip Cole
Sirtuin 6 (SIRT6) is an NAD-dependent protein deacylase that targets lysine residues in histones in the cell nucleus, where it helps maintain genome stability and links metabolism to epigenetic control. Dysregulation of SIRT6 is believed to be associated with aging and cancer, making it of pharmacological interest. In this study, we use cryogenic electron microscopy (cryo-EM) and enzymology to explore SIRT6 preference and adaptability towards different nucleosomal substrates. We have visualized a trapped complex of SIRT6 in the process of deacylating H3K27, demonstrating how SIRT6 undergoes conformational changes to remove differently positioned histone marks. Additional biochemical studies further reveal SIRT6's plasticity, which accommodates various metabolism-linked modifications such as lysine lactylation and β-hydroxybutyrylation. To further understand the basis for substrate selectivity of SIRT6, we explore the effects of an established G60A enzyme mutation, proximal H3 modifications, and small molecule modulators. These findings highlight SIRT6's versatility and provide key mechanistic insights into its molecular recognition.

22 August 2025 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
MKMingeun Kim
Mingeun Kim
YLYuxi Lin
Yuxi Lin
ENEunju Nam
Eunju Nam
DKDong Min Kang
Dong Min Kang
SLSungsu Lim
Sungsu Lim
MLMi Hee Lim
Mi Hee Lim

10 November 2023 in Advanced Science
Verified
Journal Article
Open access
ENEunju Nam
Eunju Nam
YLYuxi Lin
Yuxi Lin
JPJiyong Park
Jiyong Park
HDHyunsu Do
Hyunsu Do
JHJiyeon Han
Jiyeon Han
MLMi Hee Lim
Mi Hee Lim
Intracellular C‐terminal cleavage of the amyloid precursor protein (APP) is elevated in the brains of Alzheimer's disease (AD) patients and produces a peptide labeled APP‐C31 that is suspected to be involved in the pathology of AD. But details about the role of APP‐C31 in the development of the disease are not known. Here, this work reports that APP‐C31 directly interacts with the N‐terminal and self‐recognition regions of amyloid‐β40 (Aβ40) to form transient adducts, which facilitates the aggregation of both metal‐free and metal‐bound Aβ40 peptides and aggravates their toxicity. Specifically, APP‐C31 increases the perinuclear and intranuclear generation of large Aβ40 deposits and, consequently, damages the nucleus leading to apoptosis. The Aβ40‐induced degeneration of neurites and inflammation are also intensified by APP‐C31 in human neurons and murine brains. This study demonstrates a new function of APP‐C31 as an intracellular promoter of Aβ40 amyloidogenesis in both metal‐free and metal‐present environments, and may offer an interesting alternative target for developing treatments for AD that have not been considered thus far.